Treace Medical Concepts (TMCI) EBIT (2020 - 2025)
Historic EBIT for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to -$15.7 million.
- Treace Medical Concepts' EBIT fell 358.13% to -$15.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$48.4 million, marking a year-over-year increase of 2221.12%. This contributed to the annual value of -$55.7 million for FY2024, which is 828.34% down from last year.
- Per Treace Medical Concepts' latest filing, its EBIT stood at -$15.7 million for Q3 2025, which was down 358.13% from -$17.0 million recorded in Q2 2025.
- Treace Medical Concepts' 5-year EBIT high stood at -$204000.0 for Q4 2024, and its period low was -$21.4 million during Q2 2024.
- For the 5-year period, Treace Medical Concepts' EBIT averaged around -$10.9 million, with its median value being -$11.9 million (2022).
- As far as peak fluctuations go, Treace Medical Concepts' EBIT plummeted by 856666.67% in 2021, and later skyrocketed by 9699.2% in 2024.
- Treace Medical Concepts' EBIT (Quarter) stood at -$5.6 million in 2021, then soared by 37.52% to -$3.5 million in 2022, then plummeted by 93.94% to -$6.8 million in 2023, then skyrocketed by 96.99% to -$204000.0 in 2024, then crashed by 7584.31% to -$15.7 million in 2025.
- Its last three reported values are -$15.7 million in Q3 2025, -$17.0 million for Q2 2025, and -$15.6 million during Q1 2025.